Explore
Validate
Learn
Western blot
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Flow cytometry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AF2726 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Goat Polyclonal LMO2 Antibody
- Antibody type
- Polyclonal
- Description
- Antigen Affinity-purified. Detects human LMO2 in direct ELISAs and Western blots.
- Reactivity
- Human
- Host
- Goat
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Submitted references LMO2 is required for TAL1 DNA binding activity and initiation of definitive haematopoiesis at the haemangioblast stage.
Reprogramming mouse fibroblasts into engraftable myeloerythroid and lymphoid progenitors.
Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential.
Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
Stanulovic VS, Cauchy P, Assi SA, Hoogenkamp M
Nucleic acids research 2017 Sep 29;45(17):9874-9888
Nucleic acids research 2017 Sep 29;45(17):9874-9888
Reprogramming mouse fibroblasts into engraftable myeloerythroid and lymphoid progenitors.
Cheng H, Ang HY, A El Farran C, Li P, Fang HT, Liu TM, Kong SL, Chin ML, Ling WY, Lim EK, Li H, Huber T, Loh KM, Loh YH, Lim B
Nature communications 2016 Nov 21;7:13396
Nature communications 2016 Nov 21;7:13396
Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential.
Treanor LM, Zhou S, Janke L, Churchman ML, Ma Z, Lu T, Chen SC, Mullighan CG, Sorrentino BP
The Journal of experimental medicine 2014 Apr 7;211(4):701-13
The Journal of experimental medicine 2014 Apr 7;211(4):701-13
Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
Hirose K, Inukai T, Kikuchi J, Furukawa Y, Ikawa T, Kawamoto H, Oram SH, Göttgens B, Kiyokawa N, Miyagawa Y, Okita H, Akahane K, Zhang X, Kuroda I, Honna H, Kagami K, Goi K, Kurosawa H, Look AT, Matsui H, Inaba T, Sugita K
Blood 2010 Aug 12;116(6):962-70
Blood 2010 Aug 12;116(6):962-70
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Detection of LMO2 in K562 Human Cell Line by Flow Cytometry. Detection of LMO2 in K562 Human Cell Line by Flow Cytometry.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Detection of LMO2 in Human PBMC by Flow Cytometry Detection of LMO2 in Human PBMC by Flow Cytometry
